# CYCLOPHOSPHAMIDE
> **NDA217150** · New Drug Application · Sponsor: SANDOZ · Approved 2023-09-12
## Drug
- **FDA Application Number:** NDA217150
- **Application type:** New Drug Application
- **Brand name:** CYCLOPHOSPHAMIDE
- **Generic name:** CYCLOPHOSPHAMIDE
- **Active ingredients:** CYCLOPHOSPHAMIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ
- **Manufacturer:** Sandoz Inc
- **First approval:** 2023-09-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217150)
---
*MORVS · CC0 1.0*